Hematological malignancies encompass a diverse range of diseases, such as leukemia, lymphoma, and multiple myeloma, among others. Within the multidisciplinary treatment approach, radiation therapy ...
Dearbhla Mescal revealed that she was preparing to become an 'empty nester' right around the time that she was diagnosed with ...
Current trial data suggest that many MCED tests demonstrate high specificity, often above 99% thereby reducing the likelihood of false positives ...
Minimal residual disease (MRD) refers to the small number of myeloma cells that may remain after treatment and are not detectable using conventional response criteria. In multiple myeloma, MRD ...
Ameet Patel, MD, concludes by outlining strategies to overcome operational, financial, and payer challenges in delivering advanced multiple myeloma therapies.
A myeloma survivor in long remission shares how research, expert care and advocacy turned fear into hope as more patients ...
'I didn't cry. I just thought, right, what's the plan?' ...
Jaime Suarez-Londono, MD: Transplant for myeloma is very easy to give. On day 12 they engraft and they go home. Adverse events are not that [severe], and they get this progression-free survival [PFS] ...
Multiple myeloma is a cancer that occurs when a type of white blood cell grows out of control, causing low blood counts, bone and calcium problems, frequent infections and kidney damage. According to ...
The U.S. Food and Drug Administration (FDA) has accepted a new drug application for iberdomide combined with Darzalex ...
Legislators are working to increase regulations on PFAS, or “forever chemicals,” with Rep. Joe Bustos proposing legislation ...
State legislators are working to increase regulations on PFAS, or “forever chemicals,” with Rep. Joe Bustos of Mount Pleasant proposing legislation after his wife’s battle with cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results